Delivery Order SPE2DB22D2218-SPE2DB25FR3GH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,019.07 to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film, a buprenorphine transdermal patch indicated for pain management. The contract, which was competitively awarded without set-aside designation, was finalized on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency issued a delivery order valued at $2,180.68 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60-count package), a buprenorphine transdermal product used for pain management. This competitively awarded, firm fixed price delivery order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $2,320.49 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG Film 60s, a pharmaceutical product used for pain management. This competitively awarded contract, issued on August 25, 2025, carries a firm fixed price and is scheduled for ultimate completion on August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,026.43 to AmerisourceBergen Drug Corp for 60 units of Belbuca 750 mcg film, a buprenorphine-based pain management pharmaceutical. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film in a quantity of 60 units, with a ceiling value of $1,053.12. This firm fixed price contract, awarded on July 23, 2025, represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $1,078.44 to AmerisourceBergen Drug Corp for Belbuca 150 mcg film (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This is a $1,000.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 900 MCG FILM 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of Belbuca 600 MCG Film in quantities of 60 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,121.71 and an ultimate completion date of August 19, 2025. The award was made by the Defense Logistics Agency (DLA), the Department of Defense's logistics organization responsible for...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3GHDelivery Order
The Defense Logistics Agency awarded a $6,670.94 delivery order to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film 60S, a buprenorphine transdermal patch used for pain management. The contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical and medical supply contracts with DLA, ranging from small-value transactions to substantial orders, and was competitively selected for this award without set-aside restrictions. This delivery order exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support federal healthcare operations and military medicine programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/27/25 |